ArticleCost effectiveness and resource allocation : C/E2024
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS).
Darakhshan Masroor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it